Compare BEAM & CALY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEAM | CALY |
|---|---|---|
| Founded | 2017 | 1982 |
| Country | United States | United States |
| Employees | N/A | 28000 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 2.6B |
| IPO Year | 2019 | N/A |
| Metric | BEAM | CALY |
|---|---|---|
| Price | $27.72 | $15.30 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $50.75 | $16.50 |
| AVG Volume (30 Days) | 2.0M | ★ 2.2M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 82.31 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,000.00 | N/A |
| Revenue This Year | N/A | $9.70 |
| Revenue Next Year | $33.77 | $3.01 |
| P/E Ratio | ★ N/A | $64.24 |
| Revenue Growth | ★ 33.33 | N/A |
| 52 Week Low | $15.52 | $12.26 |
| 52 Week High | $36.44 | $16.65 |
| Indicator | BEAM | CALY |
|---|---|---|
| Relative Strength Index (RSI) | 48.95 | 62.66 |
| Support Level | $25.89 | $13.20 |
| Resistance Level | $29.06 | $15.50 |
| Average True Range (ATR) | 1.67 | 0.50 |
| MACD | 0.18 | 0.12 |
| Stochastic Oscillator | 47.35 | 86.79 |
Beam Therapeutics Inc is a biotechnology company committed to creating a new class of precision genetic medicines based on its proprietary base editing technology, with a vision of providing lifelong cures to patients suffering from serious diseases. The company is focused on its programs in the hematology and genetic disease portfolios, which comprise different product candidates in its pipeline, such as BEAM-101, which is being developed to target Sickle Cell Disease, BEAM-302, a liver-targeting lipid nanoparticle, being developed to target Alpha-1 antitrypsin deficiency, and other drug candidates including BEAM-302, BEAM-103 & 104. The company views its operations and manages its business in one operating segment, operating exclusively in the United States.
Callaway Golf Co is a golf equipment, gear and apparel company with a portfolio of world-wide brands, including Callaway Golf, Odyssey, TravisMathew, and OGIO. Callaway designs, manufactures, and sells high-performance golf clubs, golf balls, apparel, bags, and other accessories-setting the standard for performance in the game of golf. The company has two operating and reportable business segments: Golf Equipment and Apparel, Gear and Other. Geographically, the company operates in United States, Europe, Asia, and Rest of World, of which it derives maximum revenue from United States.